Varian Medical Systems (NYSE:VAR) will issue its quarterly earnings data after the market closes on Wednesday, October 23rd. Analysts expect the company to announce earnings of $1.21 per share for the quarter. Varian Medical Systems has set its FY 2019 guidance at $4.58-4.63 EPS and its FY19 guidance at $4.58-4.63 EPS.Parties that are interested in registering for the company’s conference call can do so using this link.
Varian Medical Systems (NYSE:VAR) last announced its quarterly earnings data on Wednesday, July 24th. The medical equipment provider reported $1.32 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.14 by $0.18. Varian Medical Systems had a return on equity of 24.91% and a net margin of 10.75%. The business had revenue of $825.80 million during the quarter, compared to analyst estimates of $762.29 million. During the same period last year, the company earned $1.04 earnings per share. Varian Medical Systems’s quarterly revenue was up 16.5% compared to the same quarter last year. On average, analysts expect Varian Medical Systems to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.
Shares of NYSE:VAR opened at $114.62 on Monday. Varian Medical Systems has a 1 year low of $101.42 and a 1 year high of $142.50. The business has a fifty day simple moving average of $113.10 and a 200 day simple moving average of $125.05. The firm has a market cap of $10.39 billion, a price-to-earnings ratio of 25.93, a P/E/G ratio of 2.73 and a beta of 0.87.
In other Varian Medical Systems news, SVP John W. Kuo sold 465 shares of the stock in a transaction on Monday, September 16th. The shares were sold at an average price of $116.30, for a total transaction of $54,079.50. Following the transaction, the senior vice president now directly owns 35,411 shares of the company’s stock, valued at $4,118,299.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders have sold 1,395 shares of company stock worth $158,388 over the last three months. Company insiders own 0.78% of the company’s stock.
Varian Medical Systems Company Profile
Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment.
Further Reading: What is the Fibonacci sequence?
Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.